Hope versus experience in glioblastoma
Development of new drugs for this hard-to-treat brain cancer is a slow and incremental process....
10 August, 2022Development of new drugs for this hard-to-treat brain cancer is a slow and incremental process....
10 August, 2022The Spanish Bioindustry Association (AseBio), where Laminar Pharma is a member, has published its la...
13 July, 2021Laminar Pharma has signed an agreement to sponsor the charity Sonrisa Médica, whose mission is to ma...
05 May, 2021